Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - CEN BIOTECH INC | cenb20160630_10q.htm |
| EX-31.1 - EXHIBIT 31.1 - CEN BIOTECH INC | ex31-1.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of CEN Biotech, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Paul Tidwell, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
|
1. |
The Report fully complies with requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
2. |
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
|
Date: August 15, 2016 |
| |
|
|
|
|
|
By: |
/s/ Bill Chaaban |
|
|
Bill Chaaban |
| |
|
Chief Executive and Chief Financial Officer |
| |